Sangamo Therapeutics, Inc. (LON:0R1D)
London · Delayed Price · Currency is GBP · Price in USD 0.6478
-0.0116 (-1.76%)
At close: Oct 24, 2025
Sangamo Therapeutics Market Cap
Sangamo Therapeutics has a market cap or net worth of 143.61 million as of October 27, 2025. Its market cap has increased by 14.24% in one year.
Market Cap
143.61M
Enterprise Value
132.43M
Revenue
59.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.65
Market Cap Chart
Since April 6, 2000, Sangamo Therapeutics's market cap has increased from 58.46M to 143.61M, an increase of 145.67%. That is a compound annual growth rate of 3.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 143.61M | -15.52% |
| Dec 31, 2024 | 169.99M | 124.73% |
| Dec 29, 2023 | 75.64M | -82.29% |
| Dec 30, 2022 | 427.08M | -47.07% |
| Dec 31, 2021 | 806.88M | -50.09% |
| Dec 31, 2020 | 1.62B | 120.64% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 194.33B |
| GSK plc | 65.14B |
| Haleon | 31.21B |
| Smith & Nephew | 11.69B |
| ConvaTec Group | 4.97B |
| Hikma Pharmaceuticals | 3.88B |
| HUTCHMED (China) | 1.95B |
| Genus | 1.69B |